Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biochem Pharma (BCHE) -- Ignore unavailable to you. Want to Upgrade?

To: JDN who wrote (687)	12/1/1999 3:32:00 PM
From: tuck	Respond to of 783

JDN, I have an email into IR. I even put in a few French words. But so far, I can find no info. Volume is surprisingly light. I wrote Dec. calls for a quick buck on the spike to 23 7/16. I'll post if I can find anything. A la votre, Tuck

To: JDN who wrote (687)	12/2/1999 2:45:00 PM
From: tuck	Read Replies (1) \| Respond to of 783

JDN, Here's the reply from BCHE IR: Thank you for your interest in BioChem Pharma. We typically present at a number of these types of conferences throughout the year. At the recent Robertson Stephens conference, we provided an overview of the company, our R&D pipeline, as well as an update on current operations. All of this information can be found in greater detail on our website at www.biochempharma.com Best Regards, Gordon Ngan Investor Relations BioChem Pharma So nothing new. Glad I wrote calls on my little stake. Cheers, Tuck